Indoxyl sulfate · people with CKD
1 finding from 1 review
Change in any GI upset (borborygmi) · people with CKD
It is very uncertain whether synbiotic changes change in any GI upset (borborygmi) compared with prebiotic (very low certainty).
1 finding from 1 review
Change in any GI upset (GSRS total index) · people with CKD
1 finding from 1 review
Microbiota composition · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Graft function · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Graft infection · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
eGFR · people with CKD
1 finding from 1 review
Albuminuria or proteinuria · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
GI function · adult patients after liver transplantation.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute cellular rejection in liver transplant recipients · adult patients after liver transplantation.
It is very uncertain whether synbiotics changes graft health: acute liver rejection compared with prebiotics (very low certainty).
1 finding from 1 review
Graft health · adult patients after liver transplantation.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · adult patients after liver transplantation.
It is very uncertain whether synbiotics changes adverse events compared with prebiotics (very low certainty).
1 finding from 1 review
Serious adverse events · adult patients after liver transplantation.
It is very uncertain whether synbiotics changes serious adverse events compared with prebiotics (very low certainty).
1 finding from 1 review
Death · adult patients after liver transplantation.
1 finding from 1 review
Withdrawals due to adverse events · Patients with active mild to moderate ulcerative colitis
It is very uncertain whether inulin and oligofructose 15 g changes withdrawals due to adverse events (9 weeks) compared with inulin and oligofructose 7.5 g daily (very low certainty).
1 finding from 1 review
Clinical remission · Patients with active mild to moderate ulcerative colitis
It is very uncertain whether inulin and oligofructose 15 g changes clinical remission (9 weeks) compared with inulin and oligofructose 7.5 g daily (very low certainty).
1 finding from 1 review
Clinical improvement (Mayo score) (9 weeks) · Patients with active mild to moderate ulcerative colitis
It is very uncertain whether inulin and oligofructose 15 g changes clinical improvement (Mayo score) (9 weeks) compared with inulin and oligofructose 7.5 g daily (very low certainty).
1 finding from 1 review
Quality of life · Patients with active mild to moderate ulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total adverse events (9 weeks) · Patients with active mild to moderate ulcerative colitis
It is very uncertain whether inulin and oligofructose 15 g changes total adverse events (9 weeks) compared with inulin and oligofructose 7.5 g daily (very low certainty).
1 finding from 1 review
eGFR · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found